» Articles » PMID: 39169401

Beyond Hype: Unveiling the Real Challenges in Clinical Translation of 3D Printed Bone Scaffolds and the Fresh Prospects of Bioprinted Organoids

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2024 Aug 21
PMID 39169401
Authors
Affiliations
Soon will be listed here.
Abstract

Bone defects pose significant challenges in healthcare, with over 2 million bone repair surgeries performed globally each year. As a burgeoning force in the field of bone tissue engineering, 3D printing offers novel solutions to traditional bone transplantation procedures. However, current 3D-printed bone scaffolds still face three critical challenges in material selection, printing methods, cellular self-organization and co-culture, significantly impeding their clinical application. In this comprehensive review, we delve into the performance criteria that ideal bone scaffolds should possess, with a particular focus on the three core challenges faced by 3D printing technology during clinical translation. We summarize the latest advancements in non-traditional materials and advanced printing techniques, emphasizing the importance of integrating organ-like technologies with bioprinting. This combined approach enables more precise simulation of natural tissue structure and function. Our aim in writing this review is to propose effective strategies to address these challenges and promote the clinical translation of 3D-printed scaffolds for bone defect treatment.

Citing Articles

Strategies for promoting neurovascularization in bone regeneration.

Li X, Zhao Y, Miao L, An Y, Wu F, Han J Mil Med Res. 2025; 12(1):9.

PMID: 40025573 PMC: 11874146. DOI: 10.1186/s40779-025-00596-1.


Innovative 3D printing technologies and advanced materials revolutionizing orthopedic surgery: current applications and future directions.

Cong B, Zhang H Front Bioeng Biotechnol. 2025; 13:1542179.

PMID: 40008034 PMC: 11850356. DOI: 10.3389/fbioe.2025.1542179.


Antisolvent 3D Printing of Gene-Activated Scaffolds for Bone Regeneration.

Vasilyev A, Nedorubova I, Chernomyrdina V, Meglei A, Basina V, Mironov A Int J Mol Sci. 2025; 25(24.

PMID: 39769064 PMC: 11678707. DOI: 10.3390/ijms252413300.


Protocol for engineering bone organoids from mesenchymal stem cells.

Wang J, Zhou D, Li R, Sheng S, Li G, Sun Y Bioact Mater. 2024; 45:388-400.

PMID: 39687559 PMC: 11647664. DOI: 10.1016/j.bioactmat.2024.11.017.


A Novel Triad of Bio-Inspired Design, Digital Fabrication, and Bio-Derived Materials for Personalised Bone Repair.

Dei Rossi G, Vergani L, Buccino F Materials (Basel). 2024; 17(21).

PMID: 39517582 PMC: 11547793. DOI: 10.3390/ma17215305.

References
1.
Ibrahim H, Billings C, Abdalla M, Korra A, Anderson D . In Vivo Assessment of High-Strength and Corrosion-Controlled Magnesium-Based Bone Implants. Bioengineering (Basel). 2023; 10(7). PMC: 10376803. DOI: 10.3390/bioengineering10070877. View

2.
Xu H, Liu J, Zhang Z, Xu C . A review on cell damage, viability, and functionality during 3D bioprinting. Mil Med Res. 2022; 9(1):70. PMC: 9756521. DOI: 10.1186/s40779-022-00429-5. View

3.
Fitzpatrick V, Martin-Moldes Z, Deck A, Torres-Sanchez R, Valat A, Cairns D . Functionalized 3D-printed silk-hydroxyapatite scaffolds for enhanced bone regeneration with innervation and vascularization. Biomaterials. 2021; 276:120995. PMC: 8408341. DOI: 10.1016/j.biomaterials.2021.120995. View

4.
Naghshineh N, Brown S, Cederna P, Levi B, Lisiecki J, DAmico R . Demystifying the U.S. Food and Drug Administration: understanding regulatory pathways. Plast Reconstr Surg. 2014; 134(3):559-569. DOI: 10.1097/PRS.0000000000000477. View

5.
Zhang J, Li S, He H, Han L, Zhang S, Yang L . Clinical guidelines for indications, techniques, and complications of autogenous bone grafting. Chin Med J (Engl). 2023; 137(1):5-7. PMC: 10766296. DOI: 10.1097/CM9.0000000000002691. View